The added value of quality-of-life and other patient-reported outcomes in clinical research of patients with myelodysplastic syndromes and Q&A
. Efficace F. 05/19/11; 7627
Disclosure(s): none
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}